Dupilumab for Atopic Dermatitis: 7 Years Later
The Cutaneous Connection: Splish, Splash, AD Management Starts in the Bath
Connecting COVID-19 Research to Impact on Patients With Atopic Dermatitis
The Cutaneous Connection: Pearls for Atopic Dermatitis in College-Aged Patients
Discussing Late-Breaking INTEGUMENT-PED Data With Arcutis' Chief Medical Officer, Patrick Burnett, MD, PhD, FAAD
Lawrence Eichenfield, MD: Outlining Late-Breaking INTEGUMENT-PED Data for Roflumilast in Pediatric Patients